Urovant sciences ltd. (UROV)
Income statement / TTM
Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Dec'17Sep'17
Operating expenses:
Research and development

85,179

83,379

86,247

92,198

0

0

0

0

0

General and administrative

36,142

24,317

20,546

18,585

0

0

0

0

0

Total operating expenses

121,321

107,696

106,793

110,783

0

0

0

0

0

Other income (expense):
Interest expense, net

0

0

0

-

-

-

-

-

-

Loss on disposal of furniture and equipment

0

0

0

-

-

-

-

-

-

Other income (expense), net

0

0

0

-

0

0

0

0

-

Other income (expense)

-

-

-

-

-

-

-

-

0

Loss before provision for income taxes

-124,414

-109,573

-108,477

-111,299

0

0

0

0

0

Provision for income taxes

39

62

59

47

0

0

0

0

0

Net loss

-124,453

-109,635

-108,536

-111,346

0

0

0

0

0

Net loss per common share—basic and diluted

-1.36

-0.85

-0.94

-0.77

-0.87

-1.23

-1.56

-0.47

-0.25

Weighted average common shares outstanding—basic and diluted

30,413

30,355

30,325

30,266

30,264

20,025

20,025

20,025

20,025